Caldwell Trust’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.3K Sell
237
-199
-46% -$41.4K ﹤0.01% 484
2026
Q1
$92.1K Hold
436
0.01% 413
2025
Q4
$89.6K Hold
436
0.01% 408
2025
Q3
$68.4K Buy
436
+398
+1,047% +$61.5K 0.01% 432
2025
Q2
$6.38K Hold
38
﹤0.01% 677
2025
Q1
$5.24K Hold
38
﹤0.01% 686
2024
Q4
$4.49K Hold
38
﹤0.01% 662
2024
Q3
$4.2K Hold
38
﹤0.01% 660
2024
Q2
$3.74K Buy
+38
New +$3.87K ﹤0.01% 659
2021
Q3
Sell
-225
Closed -$12.8K 735
2021
Q2
$12.8K Sell
225
-225
-50% -$13.1K ﹤0.01% 620
2021
Q1
$27.3K Sell
450
-920
-67% -$50.8K ﹤0.01% 515
2020
Q4
$73.4K Hold
1,370
0.01% 372
2020
Q3
$64.3K Hold
1,370
0.01% 382
2020
Q2
$71.5K Hold
1,370
0.01% 374
2020
Q1
$65.7K Sell
1,370
-340
-20% -$17.7K 0.01% 379
2019
Q4
$86.5K Buy
+1,710
New +$88.3K 0.01% 385

Other funds holding CAH

Caldwell Trust's CAH Position: Q2 2026 in Review

Caldwell Trust reduced its Cardinal Health (CAH) stake by 46% in Q2 2026, selling an estimated $41.4K and leaving 237 shares worth $56.3K. The position accounts for ﹤0.01% of the portfolio, ranked #484.

Caldwell Trust first reported a position in CAH in Q4 2019 and has held it in 16 quarters since. The position peaked at $92.1K in Q1 2026. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Caldwell Trust held 237 shares of Cardinal Health worth $56.3K as of Q2 2026.
  • Caldwell Trust sold 199 Cardinal Health shares in Q2 2026, an estimated $41.4K.
  • Cardinal Health made up ﹤0.01% of Caldwell Trust's portfolio in Q2 2026, its #484 holding.
  • Caldwell Trust first reported a position in Cardinal Health in Q4 2019 and has held it in 16 quarters since.
  • Caldwell Trust's Cardinal Health position peaked at $92.1K in Q1 2026.
  • 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Caldwell Trust's 13F filing for Q2 2026, filed 3 Aug 2026.